Major beta blocker mortality trials in chronic heart failure: a critical review. Heart. 1999;82(suppl 4):IV14 IV22. Altered adrenergic receptor sensitivity due to polymorphic variation.

The clinical benefit of β blockade has been proven in a variety of pathologic settings, including hypertension, angina pectoris, acute- and post-myocardial infarction, and congestive heart failure.

angiotensin receptor blockers, sacubitril/valsartan (Entresto, Novartis), continued beta-adrenergic blockade, aldosterone antagonists and HMG-CoA reductase inhibitors. Early antithrombotic ...

Atenolol blocks beta-1 receptors, which are present on the heart. This medication is a beta-blocker, prescribed for high blood pressure and to prevent heart pain and recurrence of heart attacks.

Metoprolol is a beta 1-selective (cardioselective) adrenergic receptor blocking agent ... By blocking catecholamine-induced increases in heart rate, in velocity and extent of myocardial ...

Timolol (as maleate) 0.25%, 0.5%; oph soln; contains benzalkonium chloride. Timolol maleate is a beta 1 and beta 2 (non-selective) adrenergic receptor blocking agent that does not have significant ...